Marc Dunoyer

Marc Dunoyer, AstraZeneca's chief financial officer, is the incoming chief executive of Alexion and chief strategy officer of AstraZeneca following the $39 billion cash and shares deal, which completed on Wednesday and was struck at a 45 per cent premium.